Researchers, policy-makers and business leaders from across the research and innovation community are invited to help tackle one of humanity’s biggest threats, anti-microbial resistance (AMR).
Zai Lab aims to raise $200M; Kronos Bio to seek ‘strategic’ options
Plus, news about Allogene, Telix, Cullgen, Pulmatrix, Gilead, Innocoll, Durect and Sensei: Zai Lab’s $200M offering: The Shanghai-based drugmaker is Sign up to read this